Geode Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15M Sell
1,592,048
-982
-0.1% -$9.24K ﹤0.01% 2114
2025
Q1
$8.64M Buy
1,593,030
+54,128
+4% +$293K ﹤0.01% 2378
2024
Q4
$11.5M Buy
1,538,902
+339,846
+28% +$2.53M ﹤0.01% 2284
2024
Q3
$9.58M Buy
1,199,056
+166,699
+16% +$1.33M ﹤0.01% 2408
2024
Q2
$8.98M Buy
1,032,357
+199,720
+24% +$1.74M ﹤0.01% 2391
2024
Q1
$17.2M Buy
832,637
+150,220
+22% +$3.11M ﹤0.01% 2014
2023
Q4
$15.8M Buy
682,417
+146,842
+27% +$3.39M ﹤0.01% 2053
2023
Q3
$4.28M Buy
535,575
+32,903
+7% +$263K ﹤0.01% 2723
2023
Q2
$4.37M Buy
502,672
+21,190
+4% +$184K ﹤0.01% 2760
2023
Q1
$1.42M Buy
481,482
+28,651
+6% +$84.2K ﹤0.01% 3184
2022
Q4
$1.58M Buy
452,831
+2,159
+0.5% +$7.55K ﹤0.01% 3148
2022
Q3
$3.56M Sell
450,672
-765
-0.2% -$6.05K ﹤0.01% 2856
2022
Q2
$3.55M Buy
451,437
+24,299
+6% +$191K ﹤0.01% 2883
2022
Q1
$5.19M Buy
427,138
+75,779
+22% +$921K ﹤0.01% 2778
2021
Q4
$4.3M Buy
351,359
+7,206
+2% +$88.2K ﹤0.01% 2980
2021
Q3
$3.59M Buy
344,153
+11,663
+4% +$122K ﹤0.01% 3106
2021
Q2
$2.99M Buy
332,490
+185,260
+126% +$1.67M ﹤0.01% 3144
2021
Q1
$1.5M Buy
147,230
+88,869
+152% +$902K ﹤0.01% 3394
2020
Q4
$384K Buy
58,361
+6,381
+12% +$42K ﹤0.01% 3678
2020
Q3
$269K Hold
51,980
﹤0.01% 3627
2020
Q2
$393K Sell
51,980
-37,378
-42% -$283K ﹤0.01% 3453
2020
Q1
$911K Buy
89,358
+7,335
+9% +$74.8K ﹤0.01% 3061
2019
Q4
$1.27M Buy
82,023
+2,925
+4% +$45.3K ﹤0.01% 3185
2019
Q3
$1.43M Buy
79,098
+3,600
+5% +$65.1K ﹤0.01% 3099
2019
Q2
$1.24M Buy
75,498
+32,170
+74% +$528K ﹤0.01% 3169
2019
Q1
$775K Buy
43,328
+1,568
+4% +$28K ﹤0.01% 3268
2018
Q4
$789K Buy
41,760
+10,458
+33% +$198K ﹤0.01% 3205
2018
Q3
$1.12M Buy
31,302
+2,917
+10% +$104K ﹤0.01% 3174
2018
Q2
$590K Buy
+28,385
New +$590K ﹤0.01% 3379
2018
Q1
Sell
-24,063
Closed -$259K 4054
2017
Q4
$259K Buy
24,063
+10,315
+75% +$111K ﹤0.01% 3589
2017
Q3
$164K Hold
13,748
﹤0.01% 3714
2017
Q2
$235K Sell
13,748
-557
-4% -$9.52K ﹤0.01% 3623
2017
Q1
$246K Buy
14,305
+76
+0.5% +$1.31K ﹤0.01% 3583
2016
Q4
$243K Buy
14,229
+50
+0.4% +$854 ﹤0.01% 3550
2016
Q3
$426K Buy
14,179
+13
+0.1% +$391 ﹤0.01% 3315
2016
Q2
$400K Hold
14,166
﹤0.01% 3313
2016
Q1
$379 Buy
14,166
+2,172
+18% +$58 ﹤0.01% 3367
2015
Q4
$578K Buy
11,994
+25
+0.2% +$1.21K ﹤0.01% 3201
2015
Q3
$436K Buy
11,969
+405
+4% +$14.8K ﹤0.01% 3282
2015
Q2
$435K Hold
11,564
﹤0.01% 3265
2015
Q1
$456K Buy
11,564
+476
+4% +$18.8K ﹤0.01% 3233
2014
Q4
$455K Hold
11,088
﹤0.01% 3236
2014
Q3
$490K Hold
11,088
﹤0.01% 3181
2014
Q2
$481K Hold
11,088
﹤0.01% 3184
2014
Q1
$454K Buy
11,088
+1,832
+20% +$75K ﹤0.01% 3193
2013
Q4
$367K Hold
9,256
﹤0.01% 3208
2013
Q3
$380K Hold
9,256
﹤0.01% 3069
2013
Q2
$358K Buy
+9,256
New +$358K ﹤0.01% 3020